date,title,source
Oct-17-18,Albireo Receives FDA Fast Track Designation for A4250,GlobeNewswire
Oct-26-18,"Report: Exploring Fundamental Drivers Behind Manulife Financial, Baozun, AstraZeneca, Insight Enterprises, Albireo Pharma, and Mobile TeleSystems OJSC  New Horizons, Emerging Trends, and Upcoming Developments",GlobeNewswire
Nov-08-18,Albireo to Present at Investor Conferences in November,GlobeNewswire
Nov-13-18,Albireo Reports Third Quarter 2018 Financial Results,GlobeNewswire
Dec-18-18,Albireo Granted Orphan Designation by European Commission For Lead Product Candidate A4250 for Treatment of Biliary Atresia,GlobeNewswire
